Preeclampsia is associated with a high risk of evolution burdened with complications, and the use of the sFtl-1/PIGF ratio could contribute to an objective follow-up by the nephrological and gynecological team for the optimal completion of the pregnancy and to reduce the risks of both fetal and maternal mortality. This evidence concerns the gene PIGF and preeclampsia.